Zanzalintinib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma (NCT07283731) | M.D. Anderson Cancer Center | 2026-04-14 |
Track Zanzalintinib automatically
Every clearance here is in the API, with alerts when new ones post.